Coumarin or benzoxazinone based novel carbonic anhydrase inhibitors: synthesis, molecular docking and anticonvulsant studies

References

• Duncan JS. The promise of new antiepileptic drugs. Br J Clin Pharmacol 2002;53:123–31
   PubMed Web of Science ®Google Scholar
• Perucca E. Marketed new antiepileptic drugs: are they better than old-generation agents? Ther Drug Monit 2002;24:74–80
   PubMed Web of Science ®Google Scholar
• Mulley JC, Scheffer IE, Petrov S, Berkovic SF. Channelopathies as a genetic cause of epilepsy. Curr Opin Neurol 2003;16:171–6
   PubMed Web of Science ®Google Scholar
• Lerche H, Weber YG, Jurkatt-Rott K, Lehmann-Horn F. Ion channel defects in idiopathic epilepsies. Curr Pharm Des 2005;11:2737–52
   PubMed Web of Science ®Google Scholar
• Ngugi AK, Bottomley C, Kleinschmidt I, et al. Estimation of the burden of active and life-time epilepsy. Epilepsia 2010;51:883–90
   PubMed Web of Science ®Google Scholar
• Newton CR, Garcia HH. Epilepsy in poor region of the world. Lancet 2012;380:1193–201
   PubMed Web of Science ®Google Scholar
• Dalkara S, Karakurt A. Recent progress in anticonvulsant drug research: strategies for anticonvulsant drug development and applications of antiepileptic drugs for non-epileptic central nervous system disorders. Curr Top Med Chem 2012;12:1033–71
   PubMed Web of Science ®Google Scholar
• Aggarwal M, Kondeti B, McKenna R. Anticonvulsant/antiepileptic carbonic anhydrase inhibitor: a patent review. Expert Opin Ther Patnts 2013;23:717–24
   PubMed Web of Science ®Google Scholar
• Zhu HL, Wan JB, Wang YT, et al. Medicinal compounds with antiepileptic/anticonvulsant activities. Epilepsia 2014;55:3–16
   PubMed Web of Science ®Google Scholar
• Supuran CT, Scozzafava A, Casini A. Carbonic anhydrase inhibitors. Med Res Rev 2003;123:146–89
   Web of Science ®Google Scholar
• Smith KS, Ferry JG. Prokaryotic carbonic anhydrases. FEMS Microbiol Rev 2000;24:335–66
   PubMed Web of Science ®Google Scholar
• Stams T, Christianson DW. X-ray crystallographic studies on mammalian carbonic anhydrase isoenzymes. In: Chegwidden WR, Carter ND, Edwards YH, eds. X-ray crystallographic studies on mammalian carbonic anhydrase isoenzymes: the carbonic anhydrases: New horizon. Boston: Birkhauser Verlag; 2000:159–74
   Google Scholar
• Nishimori I, Minakuchi T, Onishi S, et al. Carbonic anhydrase inhibitors: cloning, characterization and inhibition studies of the cytosolic isoenzyme III with sulphonamides. Bioorg Med Chem 2007;15:7229–36
   PubMed Web of Science ®Google Scholar
• Nishimori I, Minakuchi T, Onishi S, et al. Carbonic anhydrase inhibitors. DNA cloning, characterization and inhibition studies of human secretary isoform VI, a new target for sulfonamide and sulfomate inhibitors. J Med Chem 2007;50:381–8
   PubMed Web of Science ®Google Scholar
• Gencer N, Ergün A, Demir D. In vitro effects of some anabolic compounds on erythrocyte carbonic anhydrase I and II. J Enzyme Inhib Med Chem 2012;27:208–10
   PubMed Web of Science ®Google Scholar
• Gokce B, Gencer N, Arslan O, et al. Evaluation of in vitro effects of some analgesic drugs on erythrocyte and recombinant carbonic anhydrase I and II. J Enzyme Inhib Med Chem 2012;27:37–42
   PubMed Web of Science ®Google Scholar
• Sonmez F, Bilen C, Sumersan S, et al. In vitro inhibition effect and structure-activity relationships of some saccharin derivatives on erythrocyte carbonic anhydrase I and II. J Enzyme Inhib Med Chem 2014;29:118–23
   PubMed Web of Science ®Google Scholar
• Celik F, Arslan M, Yavuz E, et al. Synthesis and carbonic anhydrase inhibitory properties of novel 1,4-dihydropyrimidinone substituted diarylureas. J Enzyme Inhib Med Chem 2014;29:18–22
   PubMed Web of Science ®Google Scholar
• Nishimori I. Acatalytic CAs: carbonic anhydrase related proteins. In: Supuran CT, Scozzafava A, Conway J, eds. Carbonic anhydrase – its inhibitors and activators. Boca Raton: CRC Press; 2004:25–43
   Google Scholar
• Vullo D, Franchi M, Gallori E, et al. Carbonic anhydrase inhibitors: inhibition of the tumor-associated isoenzyme IX with aromatic and heterocyclic sulphonamides. Bioorg Med Chem Lett 2003;13:1005–9
   PubMed Web of Science ®Google Scholar
• Vullo D, Innocenti A, Nishimori I, et al. Carbonic anhydrase inhibitors. Inhibition of the transmembrane isozyme XII with sulphonamides – a new target for the design of antitumor and antiglaucoma drugs? Bioorg Med Chem Lett 2005;15:963–9
   PubMed Web of Science ®Google Scholar
• Lehtonen J, Shen B, Vihinen M, et al. Characterization of CA XIII, a novel member of the carbonic anhydrase isozyme family. J Biol Chem 2004;279:2719–27
   PubMed Web of Science ®Google Scholar
• Nishimori I, Vullo D, Innocenti A, et al. Carbonic anhydrase inhibitors: inhibition of the transmembrane isozyme XIV with sulphonamides. Bioorg Med Chem Lett 2005;15:3828–33
   PubMed Web of Science ®Google Scholar
• Ashida M, Brey PT. Role of the integument in insect defence: pro-phenol oxidase cascade in the cuticular matrix. Proc Natl Acad Sci USA 1995;92:10698–702
   PubMed Web of Science ®Google Scholar
• Breton S. The cellular physiology of carbonic anhydrases. J Pancreas 2001;2:159–64
   PubMedGoogle Scholar
• Durdagi S, Senturk M, Ekinci D, et al. Kinetic and docking studies of phenol-based inhibitors of carbonic anhydrase isoforms I, II, IX and XII, evidence a new binding mode within the enzyme active site. Bioorg Med Chem 2011;19:1381–9
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008;7:168–81
   PubMed Web of Science ®Google Scholar
• Casini A, Antel J, Abbate F, et al. Carbonic anhydrase inhibitors: SAR and X-ray crystallographic study for the interaction of sugar sulfamates/sulfamides with isozymes I, II and IV. Bioorg Med Chem Lett 2003;13:841–5
   PubMed Web of Science ®Google Scholar
• De Simone G, Scozzafava A, Supuran CT. Which carbonic anhydrases are targeted by the antiepileptic sulphonamides and sulfamates? Chem Biol Drug Des 2009;74:317–21
   PubMed Web of Science ®Google Scholar
• Temperini C, Innocenti A, Scozzafava A, et al. The coumarin binding side in carbonic anhydrase accommodates structurally diverse inhibitors: the antiepileptic lacosamide as an example and lead molecule for novel classes of carbonic anhydrase inhibitors. J Med Chem 2010;53:850–4
   PubMed Web of Science ®Google Scholar
• Maresca A, Temperini C, Vu H, et al. Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors. J Am Chem Soc 2009;131:3057–62
   PubMed Web of Science ®Google Scholar
• Maresca A, Temperini C, Pochet L, et al. Deciphering the mechanism of carbonic anhydrase inhibition with coumarins and thio coumarins. J Med Chem 2010;53:335–44
   PubMed Web of Science ®Google Scholar
• D’Ambrosio K, Carradori S, Monti SM, et al. Out of the active site binding pocket for carbonic anhydrase inhibitors. Chem Commun 2015;51:302–5
   PubMed Web of Science ®Google Scholar
• Thiry A, Dogne JM, Supuran CT, Masareel B. Carbonic anhydrase inhibitors as anticonvulsant agents. Curr Top Med Chem 2007;7:855–64
   PubMed Web of Science ®Google Scholar
• Maren TH, Conroy CW, Wynns GC, Godman DR. Renal and cerebrospinal fluid formation pharmacology of a high molecular weight carbonic anhydrase inhibitor. J Pharmacol Exp Ther 1997;280:98–104
   PubMed Web of Science ®Google Scholar
• Sun MK, Alkon DL. Carbonic anhydrase gating of attention: memory therapy and enhancement. Trends Pharmacol Sci 2002;23:83–9
   PubMed Web of Science ®Google Scholar
• Anand P, Singh B, Singh M. A review on coumarins as acetylcholinesterase inhibitors for Alzheimer’s disease. Bioorg Med Chem 2012;20:1175–80
   PubMed Web of Science ®Google Scholar
• Yu D, Suzuki M, Xie L, et al. Recent progress in the development of coumarin derivatives as potent anti-HIV agents. Med Res Rev 2003;23:322–45
   PubMed Web of Science ®Google Scholar
• Tosun F, Kızılay CA, Erol K, et al. Anticonvulsant activity of furanocoumarins and the essential oil obtained from the Heracleum crenatifolium. Food Chem 2008;107:990–3
   Web of Science ®Google Scholar
• Bansal Y, Silakari O. The therapeutic journey of benzimidazoles: a review. Bioorg Med Chem 2012;20:6208–36
   PubMed Web of Science ®Google Scholar
• Nair MG, Salter DC, Kisliuk RL, et al. Folate analogs. 22. Synthesis and biological evaluation of two analogs of dihydro folic acid possessing a 7,8-dihydro-8-oxapterin ring system. J Med Chem 1983;26:1164–8
   PubMed Web of Science ®Google Scholar
• Katsura Y, Nishino S, Takasugi H. Studies on antiulcer drugs. I. Synthesis and antiulcer activities of imidazo[1,2-alpha]pyrdnyl-2-oxobenzoxazolidines-3-oxo-2H-1,4-benzoxazines and related compounds. Chem Pharm Bull 1991;39:2937–43
   PubMed Web of Science ®Google Scholar
• Kajino M, Shibouta Y, Nishikawa K, Megura K. Synthesis and biological activities of new 2-substitute 1,4-benzoxazine derivatives. Chem Pharm Bull 1991;38:2896–905
   Web of Science ®Google Scholar
• Wahidulla S, Bhattaeharje JJ. Benzoxazinoids from Acanthus illicifolius. J Indian Inst Sci 2001;81:485–90
   Google Scholar
• Fang L, Zuo H, Li ZB, et al. Synthesis of benzo[b][1,4]oxazin-3(4H)-ones via smiles rearrangement for antimicrobial activity. Med Chem Res 2011;20:670–7
   Web of Science ®Google Scholar
• Li X, Liu N, Zhang H, et al. Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. Bioorg Med Chem Lett 2010;20:6306–9
   PubMed Web of Science ®Google Scholar
• Fringuelli R, Giacche N, Milanese L, et al. 1,4-Benzoxazine derivatives with antifungal activity. Bioorg Med Chem 2009;17:3838–46
   PubMed Web of Science ®Google Scholar
• Turk CF, Krapcho J, Miche IM, Weinryb I. Synthesis and central nervous system activity of 2-arylidene-4-aminoalkyl-2H-1,4-benzoxazin-3(4H)-ones and related compounds. J Med Chem 1997;20:729–32
   Web of Science ®Google Scholar
• Ozdemir I, Sahin N, Gok Y, et al. In-situ generated 1-alkylbenzimidazole-palladium catalyst for the Suzuki coupling of aryl chlorides. J Mol Catal A Chem 2005;234:181–5
   Web of Science ®Google Scholar
• Frasinyuk MS, Vinogradova VI, Bondarenko SP, Khilya VP. Synthesis of cytosine derivatives of coumarins. Chem Nat Compounds 2007;43:176–80
   Web of Science ®Google Scholar
• Karatas MO, Alici B, Cakir U, et al. New coumarin derivatives as carbonic anhydrase inhibitors. Artif Cells Nanomedicine Biotechnol 2014;42:192–8
   PubMed Web of Science ®Google Scholar
• Karatas MO, Alici B, Cakir U, et al. Synthesis and carbonic anhydrase inhibitory properties of novel coumarin derivatives. J Enzyme Inhib Med Chem 2013;28:299–304
   PubMed Web of Science ®Google Scholar
• Arslan O, Nalbantoglu B, Demir N, et al. A new method for the purification of carbonic anhydrase isozymes by affinity chromatography. Turk J Med Sci 1996;26:163–6
   Google Scholar
• Maren TH. A simplified micromethod for the determination of carbonic anhydrase and its inhibitors. J Pharmacol Exp Ther 1960;130:2629–34
   Web of Science ®Google Scholar
• Gumus A, Karadeniz S, Ugras HI, et al. Synthesis, complexation and biological activity studies of 4-aminomethyl-7,8-dihydroxy coumarins and their crown ether derivatives. J Heterocyclic Chem 2010;47:1127–33
   Web of Science ®Google Scholar
• Demir S, Zengin Z, Ozdemir I. Potential N-heterocyclic carbene precursors in the palladium-catalyzed Heck reaction. Heteroatom Chem 2013;24:77–83
   Web of Science ®Google Scholar
• Buyukkidan N, Bulbul M, Kasimogulları R, Buyukkidan B. Synthesis and characterization of metal complexes of heterocyclic sulfonamide as carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem 2013;28:311–15
   PubMed Web of Science ®Google Scholar